Passkey Therapeutics
- Biotech or pharma, therapeutic R&D
Passkey Therapeutics is discovering and developing synergistic multi-functional therapeutics (SMThs) for complex, commonly occurring diseases. Passkey’s proprietary platform uses computational genetics to unlock a vast new target space, with applicability to many diseases, and facilitates the discovery and development of multifunctional drugs to target these novel targets. We’re currently exploring indications in cancer, metabolic disease, immunology, and neurodegenerative diseases. The biological complexity that has historically made major diseases difficult to address is instead turned into an advantage by the Passkey approach to drug discovery. More information is available at: passkeytx.com
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}